Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.270
-0.050 (-1.16%)
May 11, 2026, 11:50 AM EDT - Market open
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $530.69 million as of May 11, 2026. Its market cap has increased by 88.33% in one year.
Market Cap
530.69M
Enterprise Value
465.68M
1-Year Change
88.33%
Ranking
Category
Stock Price
$4.27
Market Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has increased from $393.23M to $530.69M, an increase of 34.96%. That is a compound annual growth rate of 3.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 536.91M | -31.88% |
| Dec 31, 2025 | 788.14M | 142.81% |
| Dec 31, 2024 | 324.59M | 140.67% |
| Dec 29, 2023 | 134.87M | 176.07% |
| Dec 30, 2022 | 48.85M | -68.73% |
| Dec 31, 2021 | 156.24M | -13.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amphastar Pharmaceuticals | 837.77M |
| Eton Pharmaceuticals | 811.22M |
| Esperion Therapeutics | 808.25M |
| BioAge Labs | 798.72M |
| Ironwood Pharmaceuticals | 694.67M |
| Tilray Brands | 663.21M |
| Kamada | 496.27M |
| Emergent BioSolutions | 490.16M |